| Year |
Citation |
Score |
| 2024 |
Kamuyu G, Coelho da Silva F, Tenet V, Schussler J, Godi A, Herrero R, Porras C, Mirabello L, Schiller JT, Sierra MS, Kreimer AR, Clifford GM, Beddows S. Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection. Nature Communications. 15: 1608. PMID 38383518 DOI: 10.1038/s41467-024-45807-w |
0.459 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, et al. Reproducible and clinically translatable deep neural networks for cervical screening. Scientific Reports. 13: 21772. PMID 38066031 DOI: 10.1038/s41598-023-48721-1 |
0.43 |
|
| 2023 |
Stephens ES, Dema E, McGee-Avila JK, Shiels MS, Kreimer AR, Shing JZ. Human Papillomavirus Awareness by Educational Level and by Race and Ethnicity. Jama Network Open. 6: e2343325. PMID 37962885 DOI: 10.1001/jamanetworkopen.2023.43325 |
0.556 |
|
| 2023 |
Schiller JT, Kreimer AR. An HPV vaccine from India: broadening possibilities for cervical cancer control. The Lancet. Oncology. 24: 1288-1289. PMID 37949087 DOI: 10.1016/S1470-2045(23)00535-1 |
0.651 |
|
| 2023 |
Schuind AE, Rees H, Schiller J, Mugo N, Dull P, Barnabas R, Clifford GM, Liu G, Madhi SA, Morse RB, Moscicki AB, Palefsky JM, Plotkin S, Sierra MS, Slifka MK, ... ... Kreimer AR, et al. State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop. Preventive Medicine Reports. 35: 102331. PMID 37576844 DOI: 10.1016/j.pmedr.2023.102331 |
0.633 |
|
| 2023 |
Befano B, Campos NG, Egemen D, Herrero R, Schiffman M, Porras C, Lowy DR, Rodriguez AC, Schiller JT, Ocampo R, Hildesheim A, Sampson JN, Das S, Kreimer AR, Cheung LC. Estimating human papillomavirus vaccine efficacy from a single-arm trial: Proof-of-principle in the Costa Rica Vaccine Trial. Journal of the National Cancer Institute. PMID 37040086 DOI: 10.1093/jnci/djad064 |
0.489 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, et al. Reproducible and Clinically Translatable Deep Neural Networks for Cancer Screening. Research Square. PMID 36909463 DOI: 10.21203/rs.3.rs-2526701/v1 |
0.444 |
|
| 2023 |
Shing JZ, Corbin J, Kreimer AR, Carvajal LJ, Taparra K, Shiels MS, Vo JB. HPV-Associated Cancer Incidence by Disaggregated Asian American, Native Hawaiian, and Other Pacific Islander Ethnicity. Jnci Cancer Spectrum. PMID 36790075 DOI: 10.1093/jncics/pkad012 |
0.599 |
|
| 2023 |
Carvajal LJ, Shing JZ, Vanegas JC, González E, Guillén D, Sierra MS, Hildesheim A, Porras C, Herrero R, Torres G, Shiels MS, Calderón A, Kreimer AR. Trends in incidence rates of head and neck squamous cell carcinomas overall and by potential relatedness to human papillomavirus, Costa Rica 2006 to 2015. International Journal of Cancer. PMID 36650690 DOI: 10.1002/ijc.34437 |
0.626 |
|
| 2022 |
Kreimer AR, Cernuschi T, Rees H, Brotherton JML, Porras C, Schiller J. Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule. Journal of the National Cancer Institute. PMID 36194015 DOI: 10.1093/jnci/djac189 |
0.631 |
|
| 2022 |
Baisley K, Kemp TJ, Kreimer AR, Basu P, Changalucha J, Hildesheim A, Porras C, Whitworth H, Herrero R, Lacey CJ, Schiller JT, Lucas E, Mutani P, Dillner J, Indangasi J, et al. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. The Lancet. Global Health. 10: e1485-e1493. PMID 36113532 DOI: 10.1016/S2214-109X(22)00306-0 |
0.611 |
|
| 2022 |
Markowitz LE, Drolet M, Lewis RM, Lemieux-Mellouki P, Pérez N, Jit M, Brotherton JM, Ogilvie G, Kreimer AR, Brisson M. Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs. Vaccine. PMID 35965239 DOI: 10.1016/j.vaccine.2022.06.065 |
0.483 |
|
| 2022 |
Sierra MS, Tsang SH, Porras C, Herrero R, Sampson JN, Cortes B, Schussler J, Wagner S, Carvajal L, Quint W, Kreimer AR, Hu S, Rodriguez AC, Romero B, Hildesheim A, et al. Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial. Sexually Transmitted Infections. PMID 35842229 DOI: 10.1136/sextrans-2022-055434 |
0.677 |
|
| 2022 |
Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN, Schussler J, Schiller JT, Lowy DR, Sierra MS, Carvajal L, Kreimer AR. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. The Lancet. Oncology. 23: 940-949. PMID 35709811 DOI: 10.1016/S1470-2045(22)00291-1 |
0.647 |
|
| 2022 |
Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, Schroeder L, Hildesheim A, Pawlita M, D'Souza G, Visvanathan K, Langseth H, Schlecht NF, Tinker LF, Agalliu I, ... ... Kreimer AR, et al. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101785. PMID 35700419 DOI: 10.1200/JCO.21.01785 |
0.577 |
|
| 2022 |
Hu SY, Kreimer AR, Porras C, Guillén D, Alfaro M, Darragh TM, Stoler MH, Villegas LF, Ocampo R, Rodriguez AC, Schiffman M, Tsang SH, Lowy DR, Schiller JT, Schussler J, et al. Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial. Journal of the National Cancer Institute. PMID 35640980 DOI: 10.1093/jnci/djac107 |
0.6 |
|
| 2022 |
Adebamowo SN, Befano B, Cheung LC, Rodriguez AC, Demarco M, Rydzak G, Chen X, Porras C, Herrero R, Kim JJ, Castle PE, Wentzensen N, Kreimer AR, Schiffman M, Campos NG. Different Human Papillomavirus Types Share Early Natural History Transitions in Immunocompetent Women. International Journal of Cancer. PMID 35603904 DOI: 10.1002/ijc.34128 |
0.664 |
|
| 2022 |
Tsang SH, Schiller JT, Porras C, Kemp TJ, Herrero R, Schussler J, Sierra MS, Cortes B, Hildesheim A, Lowy DR, Rodríguez AC, Romero B, Çuburu N, Shing JZ, Pinto LA, ... ... Kreimer AR, et al. HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial. Npj Vaccines. 7: 40. PMID 35351898 DOI: 10.1038/s41541-022-00431-x |
0.67 |
|
| 2022 |
Porras C, Sampson JN, Herrero R, Gail MH, Cortés B, Hildesheim A, Cyr J, Romero B, Schiller JT, Montero C, Pinto LA, Schussler J, Coronado K, Sierra MS, Kim JJ, ... ... Kreimer AR, et al. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial. Vaccine. 40: 76-88. PMID 34857420 DOI: 10.1016/j.vaccine.2021.11.041 |
0.521 |
|
| 2021 |
Campos NG, Chaturvedi AK, Kreimer AR. Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies. Journal of the National Cancer Institute. PMID 33876237 DOI: 10.1093/jnci/djab081 |
0.574 |
|
| 2020 |
Sierra MS, Tsang SH, Hu S, Porras C, Herrero R, Kreimer AR, Schussler J, Boland J, Wagner S, Cortes B, Rodríguez AC, Quint W, van Doorn LJ, Schiffman M, Sampson JN, et al. Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT). The Journal of Infectious Diseases. PMID 33326576 DOI: 10.1093/infdis/jiaa768 |
0.676 |
|
| 2020 |
Porras C, Tsang SH, Herrero R, Guillén D, Darragh TM, Stoler MH, Hildesheim A, Wagner S, Boland J, Lowy DR, Schiller JT, Schiffman M, Schussler J, Gail MH, Quint W, ... ... Kreimer AR, et al. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. The Lancet. Oncology. 21: 1643-1652. PMID 33271093 DOI: 10.1016/S1470-2045(20)30524-6 |
0.661 |
|
| 2020 |
Tota JE, Struyf F, Hildesheim A, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, et al. Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials. The Journal of Infectious Diseases. PMID 32887990 DOI: 10.1093/Infdis/Jiaa561 |
0.684 |
|
| 2020 |
Tsang SH, Basu P, Bender N, Herrero R, Kemp TJ, Kreimer AR, Müller M, Panicker G, Pawlita M, Pinto LA, Sampson JN, Sankaranarayanan R, Schussler J, Sehr P, Sierra MS, et al. Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. Vaccine. PMID 32713678 DOI: 10.1016/J.Vaccine.2020.07.017 |
0.605 |
|
| 2020 |
Hu SY, Tsang SH, Chen F, Pan QJ, Zhang WH, Hong Y, Sampson JN, Hildesheim A, Zhao FH, Kreimer AR. Association between Common Vaginal Infections and Cervical Non-HPV16/18 Infection in HPV-Vaccinated Women. The Journal of Infectious Diseases. PMID 32614401 DOI: 10.1093/Infdis/Jiaa384 |
0.706 |
|
| 2020 |
Kreimer AR, Chaturvedi AK, Alemany L, Anantharaman D, Bray F, Carrington M, Doorbar J, D'Souza G, Fakhry C, Ferris RL, Gillison M, Neil Hayes D, Hildesheim A, Huang SH, Kowalski LP, et al. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncology. 108: 104736. PMID 32502860 DOI: 10.1016/J.Oraloncology.2020.104736 |
0.601 |
|
| 2020 |
Tsang SH, Sampson JN, Schussler J, Porras C, Wagner S, Boland J, Cortes B, Lowy DR, Schiller JT, Schiffman M, Kemp TJ, Rodriguez AC, Quint W, Gail MH, Pinto LA, ... ... Kreimer AR, et al. Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial. Journal of the National Cancer Institute. PMID 32091596 DOI: 10.1093/Jnci/Djaa010 |
0.649 |
|
| 2020 |
Kreimer AR, Sampson JN, Porras C, Schiller JT, Kemp T, Herrero R, Wagner S, Boland J, Schussler J, Lowy DR, Chanock S, Roberson D, Sierra MS, Tsang SH, Schiffman M, et al. Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial. Journal of the National Cancer Institute. PMID 32091594 DOI: 10.1093/Jnci/Djaa011 |
0.638 |
|
| 2020 |
Kreimer AR, Cernuschi T, Rees H, Saslow D, Porras C, Schiller J. Prioritisation of the human papillomavirus vaccine in a time of constrained supply. The Lancet. Child & Adolescent Health. PMID 32078808 DOI: 10.1016/S2352-4642(20)30038-9 |
0.452 |
|
| 2019 |
Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D. Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. PMID 31870572 DOI: 10.1016/J.Vaccine.2019.12.017 |
0.463 |
|
| 2019 |
Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, et al. Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials. Journal of the National Cancer Institute. PMID 31697384 DOI: 10.1093/Jnci/Djz222 |
0.703 |
|
| 2019 |
Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, et al. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. The Journal of Infectious Diseases. PMID 31536132 DOI: 10.1093/Infdis/Jiz324 |
0.637 |
|
| 2019 |
Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, et al. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. The Lancet. Infectious Diseases. PMID 31204304 DOI: 10.1016/S1473-3099(19)30164-1 |
0.682 |
|
| 2019 |
Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, et al. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 31185496 DOI: 10.1093/Annonc/Mdz138 |
0.647 |
|
| 2018 |
Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T. Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research. Cancer. PMID 29499070 DOI: 10.1002/Cncr.31256 |
0.425 |
|
| 2018 |
Beachler D, Pinto L, Kemp TJ, Nyitray AG, Hildesheim A, Viscidi R, Schussler J, Kreimer AR, Giuliano AR. An examination of HPV16 natural immunity in men who have sex with men (MSM) in the HPV in Men (HIM) study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29475967 DOI: 10.1158/1055-9965.Epi-17-0853 |
0.651 |
|
| 2018 |
Sampson JN, Hildesheim A, Herrero R, Gonzalez P, Kreimer A, Gail MH. Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine. Contemporary Clinical Trials. PMID 29474934 DOI: 10.1016/J.Cct.2018.02.010 |
0.66 |
|
| 2018 |
Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, et al. Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. PMID 29366703 DOI: 10.1016/J.Vaccine.2017.12.078 |
0.614 |
|
| 2018 |
Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, ... ... Kreimer AR, et al. Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. Journal of the National Cancer Institute. 110. PMID 28954299 DOI: 10.1093/Jnci/Djx158 |
0.674 |
|
| 2017 |
Lang Kuhs KA, Kreimer AR, Trivedi S, Holzinger D, Pawlita M, Pfeiffer RM, Gibson SP, Schmitt NC, Hildesheim A, Waterboer T, Ferris RL. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Cancer. PMID 28950407 DOI: 10.1002/Cncr.30966 |
0.639 |
|
| 2017 |
Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, ... ... Kreimer AR, et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 170: 1164-1174.e6. PMID 28886384 DOI: 10.1016/J.Cell.2017.08.001 |
0.7 |
|
| 2017 |
Beachler DC, Lang Kuhs KA, Struijk L, Schussler J, Herrero R, Porras C, Hildesheim A, Cortes B, Sampson J, Quint W, Gonzalez P, Kreimer AR. The Natural History of Oral Human Papillomavirus in Young Costa Rican Women. Sexually Transmitted Diseases. 44: 442-449. PMID 28608796 DOI: 10.1097/Olq.0000000000000625 |
0.718 |
|
| 2017 |
Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, et al. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. Journal of the National Cancer Institute. 109. PMID 28376197 DOI: 10.1093/Jnci/Djx005 |
0.632 |
|
| 2017 |
Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WA, Porras C, Quint W, et al. Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials. Journal of the National Cancer Institute. 109. PMID 28132019 DOI: 10.1093/Jnci/Djw300 |
0.667 |
|
| 2016 |
Beachler DC, Gonzales FA, Kobrin SC, Kreimer AR. HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States. Papillomavirus Research (Amsterdam, Netherlands). 2: 11-16. PMID 31690424 DOI: 10.1016/j.pvr.2015.12.001 |
0.581 |
|
| 2016 |
Beachler DC, Waterboer T, Campbell CM, Ingles DJ, Kuhs KA, Nyitray AG, Hildesheim A, Pawlita M, Kreimer AR, Giuliano AR. HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection. Papillomavirus Research (Amsterdam, Netherlands). 2: 141-144. PMID 28239675 DOI: 10.1016/J.Pvr.2016.07.003 |
0.715 |
|
| 2016 |
Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS. Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecologic Oncology. PMID 27894752 DOI: 10.1016/J.Ygyno.2016.11.031 |
0.44 |
|
| 2016 |
Brisson M, Drolet M, Bénard É, Kreimer AR. Effect of HPV on cervical cancer screening in Alberta. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 188: 1035. PMID 27698024 DOI: 10.1503/Cmaj.1150121 |
0.693 |
|
| 2016 |
Anantharaman D, Muller DC, Lagiou P, Ahrens W, Holcátová I, Merletti F, Kjærheim K, Polesel J, Simonato L, Canova C, Castellsague X, Macfarlane TV, Znaor A, Thomson P, Robinson M, ... ... Kreimer AR, et al. Combined effects of smoking and HPV16 in oropharyngeal cancer. International Journal of Epidemiology. PMID 27197530 DOI: 10.1093/Ije/Dyw069 |
0.603 |
|
| 2016 |
Lang Kuhs KA, Pawlita M, Gibson SP, Schmitt NC, Trivedi S, Argiris A, Kreimer AR, Ferris RL, Waterboer T. Characterization of human papillomavirus antibodies in individuals with head and neck cancer. Cancer Epidemiology. 42: 46-52. PMID 27010729 DOI: 10.1016/J.Canep.2016.03.003 |
0.667 |
|
| 2016 |
Pierce Campbell CM, Viscidi RP, Torres BN, Lin HY, Fulp W, Abrahamsen M, Lazcano-Ponce E, Villa LL, Kreimer AR, Giuliano AR. Human papillomavirus (HPV) L1 serum antibodies and risk of subsequent oral HPV acquisition in men: The HIM Study. The Journal of Infectious Diseases. PMID 26931445 DOI: 10.1093/Infdis/Jiw083 |
0.703 |
|
| 2016 |
Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S. Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines. International Journal of Cancer. Journal International Du Cancer. PMID 26916230 DOI: 10.1002/Ijc.30063 |
0.693 |
|
| 2016 |
Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M, Sidawy M, Schiller JT, Lowy DR, Herrero R. Impact of Human Papillomavirus (HPV) 16 and 18 Vaccination on Prevalent Infections and Rates of Cervical Lesions After Excisional Treatment. American Journal of Obstetrics and Gynecology. PMID 26892991 DOI: 10.1016/J.Ajog.2016.02.021 |
0.625 |
|
| 2016 |
Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, Kreimer AR, Hayes RB, Freedman ND, Burk RD. Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer. Jama Oncology. PMID 26794505 DOI: 10.1001/Jamaoncol.2015.5504 |
0.564 |
|
| 2016 |
Beachler DC, Gonzales FA, Kobrin SC, Kreimer AR. HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States. Papillomavirus Research. 2: 11-16. PMID 26783559 DOI: 10.1016/J.Pvr.2015.12.001 |
0.613 |
|
| 2016 |
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, et al. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. Journal of the National Cancer Institute. 108. PMID 26467666 DOI: 10.1093/Jnci/Djv302 |
0.711 |
|
| 2015 |
Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis. The Journal of Infectious Diseases. PMID 26690341 DOI: 10.1093/Infdis/Jiv753 |
0.69 |
|
| 2015 |
Kreimer AR, Struyf F, Hildesheim A, David MP, Wheeler CM. Fewer than three doses of HPV vaccine - Authors' reply. The Lancet. Oncology. 16: e424-5. PMID 26370346 DOI: 10.1016/S1470-2045(15)00196-5 |
0.642 |
|
| 2015 |
Panagiotou OA, Befano BL, Gonzalez P, Rodríguez AC, Herrero R, Schiller JT, Kreimer AR, Schiffman M, Hildesheim A, Wilcox AJ, Wacholder S. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. Bmj (Clinical Research Ed.). 351: h4358. PMID 26346155 DOI: 10.1136/Bmj.H4358 |
0.528 |
|
| 2015 |
Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1548-56. PMID 26224796 DOI: 10.1158/1055-9965.Epi-15-0044 |
0.333 |
|
| 2015 |
Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. The Lancet. Oncology. 16: 775-86. PMID 26071347 DOI: 10.1016/S1470-2045(15)00047-9 |
0.642 |
|
| 2015 |
Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, Kreimer AR, Yang G, Adami HO, Alavanja MC, Beane Freeman LE, Boeing H, Buring J, Chaturvedi A, Chen Y, et al. Anthropometry and head and neck cancer:a pooled analysis of cohort data. International Journal of Epidemiology. 44: 673-81. PMID 26050257 DOI: 10.1093/Ije/Dyv059 |
0.331 |
|
| 2015 |
Giuliano AR, Kreimer AR, de Sanjose S. The beginning of the end: vaccine prevention of HPV-driven cancers. Journal of the National Cancer Institute. 107: djv128. PMID 25911509 DOI: 10.1093/Jnci/Djv128 |
0.679 |
|
| 2015 |
Gonzalez P, Hildesheim A, Herrero R, Katki H, Wacholder S, Porras C, Safaeian M, Jimenez S, Darragh TM, Cortes B, Befano B, Schiffman M, Carvajal L, Palefsky J, Schiller J, ... ... Kreimer AR, et al. Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica. Vaccine. 33: 2141-51. PMID 25796338 DOI: 10.1016/J.Vaccine.2015.03.015 |
0.664 |
|
| 2015 |
Kreimer AR, Brennan P, Lang Kuhs KA, Waterboer T, Clifford G, Franceschi S, Michel A, Willhauck-Fleckenstein M, Riboli E, Castellsagué X, Hildesheim A, Fortner RT, Kaaks R, Palli D, Ljuslinder I, et al. Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 877-84. PMID 25667279 DOI: 10.1200/Jco.2014.57.8435 |
0.682 |
|
| 2015 |
Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M. The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. Journal of the National Cancer Institute. 107. PMID 25650316 DOI: 10.1093/Jnci/Dju436 |
0.658 |
|
| 2015 |
Lang Kuhs KA, Anantharaman D, Waterboer T, Johansson M, Brennan P, Michel A, Willhauck-Fleckenstein M, Purdue MP, Holcátová I, Ahrens W, Lagiou P, Polesel J, Simonato L, Merletti F, Healy CM, ... ... Kreimer AR, et al. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 683-9. PMID 25623733 DOI: 10.1158/1055-9965.Epi-14-1217 |
0.693 |
|
| 2015 |
Pierce Campbell CM, Kreimer AR, Lin HY, Fulp W, O'Keefe MT, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR. Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study. Cancer Prevention Research (Philadelphia, Pa.). 8: 190-6. PMID 25575501 DOI: 10.1158/1940-6207.Capr-14-0296 |
0.686 |
|
| 2015 |
Porras C, Hildesheim A, González P, Schiffman M, Rodríguez AC, Wacholder S, Jiménez S, Quint W, Guillen D, Kreimer AR, Herrero R. Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing. Journal of the National Cancer Institute. 107: 400. PMID 25479804 DOI: 10.1093/Jnci/Dju400 |
0.627 |
|
| 2015 |
Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. International Journal of Cancer. Journal International Du Cancer. 136: 2752-60. PMID 25043222 DOI: 10.1002/Ijc.29082 |
0.701 |
|
| 2015 |
Agalliu I, Chen Z, Wang T, Ludvigsen R, Teras L, Kreimer AR, Hayes RB, Gapstur S, Burk RD. Abstract LB-181: Oral HPV DNA detection and subsequent risk of head and neck cancers in two prospective cohorts Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-181 |
0.698 |
|
| 2015 |
Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Jimenez S, Struijk L, Schussler J, Hildesheim A, Gonzalez P. Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure Cancer Research. 75: 4680-4680. DOI: 10.1158/1538-7445.Am2015-4680 |
0.72 |
|
| 2015 |
Panagiotou OA, Befano BL, Gonzalez P, Rodríguez AC, Herrero R, Schiller JT, Kreimer AR, Schifman M, Hildesheim A, Wilcox AJ, Wacholder S, Jiménez SE, Porras C, Lowy DR, Sherman M, et al. Efect of bivalent human papillomavirus vaccination on pregnancy outcomes: Long term observational follow-up in the Costa Rica HPV vaccine trial Bmj (Online). 351. DOI: 10.1136/bmj.h4358 |
0.489 |
|
| 2015 |
Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: Combined analysis of data from the Costa Rica Vaccine and PATRICIA trials The Lancet Oncology. DOI: 10.1016/S1470-2045(15)00047-9 |
0.487 |
|
| 2014 |
Lang Kuhs KA, Porras C, Schiller JT, Rodriguez AC, Schiffman M, Gonzalez P, Wacholder S, Ghosh A, Li Y, Lowy DR, Kreimer AR, Poncelet S, Schussler J, Quint W, van Doorn LJ, et al. Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. American Journal of Epidemiology. 180: 599-607. PMID 25139208 DOI: 10.1093/Aje/Kwu168 |
0.714 |
|
| 2014 |
Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, ... ... Kreimer AR, et al. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial. The Journal of Infectious Diseases. 210: 1890-9. PMID 24958910 DOI: 10.1093/Infdis/Jiu357 |
0.688 |
|
| 2014 |
Kreimer AR, Safaeian M, Hildesheim A. Number of human papillomavirus vaccine doses and condyloma. Jama. 311: 2439. PMID 24938569 DOI: 10.1001/Jama.2014.5009 |
0.479 |
|
| 2014 |
Kreimer AR. Prospects for prevention of HPV-driven oropharynx cancer. Oral Oncology. 50: 555-9. PMID 23876626 DOI: 10.1016/J.Oraloncology.2013.06.007 |
0.735 |
|
| 2014 |
Hildesheim A, Wacholder S, Catteau G, Struyf F, Dubin G, Herrero R, Alfaro M, Bratti MC, Cortés B, Espinoza A, Estrada Y, González P, Guil-Lén D, Jiménez SE, Morales J, ... ... Kreimer AR, et al. Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial Vaccine. 32: 5087-5097. DOI: 10.1016/j.vaccine.2014.06.038 |
0.589 |
|
| 2013 |
Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, Herrero R, Kemp T, Shelton G, Quint W, van Doorn LJ, et al. Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial. Cancer Prevention Research (Philadelphia, Pa.). 6: 1242-50. PMID 24189371 DOI: 10.1158/1940-6207.Capr-13-0203 |
0.631 |
|
| 2013 |
Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, ... ... Kreimer AR, et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. The Journal of Infectious Diseases. 208: 1643-52. PMID 24014882 DOI: 10.1093/Infdis/Jit369 |
0.628 |
|
| 2013 |
Pfeiffer RM, Park Y, Kreimer AR, Lacey JV, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. Plos Medicine. 10: e1001492. PMID 23935463 DOI: 10.1371/Journal.Pmed.1001492 |
0.304 |
|
| 2013 |
Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, ... Kreimer AR, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. Plos One. 8: e68329. PMID 23873171 DOI: 10.1371/Journal.Pone.0068329 |
0.716 |
|
| 2013 |
Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, Hildesheim A, Villa LL, Salmerón JJ, Lazcano-Ponce E, Giuliano AR. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet (London, England). 382: 877-87. PMID 23827089 DOI: 10.1016/S0140-6736(13)60809-0 |
0.672 |
|
| 2013 |
Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, Tjønneland A, Overvad K, Quirós JR, González CA, Sánchez MJ, Larrañaga N, Navarro C, Barricarte A, Travis RC, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2708-15. PMID 23775966 DOI: 10.1200/Jco.2012.47.2738 |
0.699 |
|
| 2013 |
Brennan P, Johannson M, Anantharaman D, Pawlita M, Kreimer A. Abstract 3625: An analysis of human papilloma virus (HPV) E6 antibodies and risk of head and neck cancer: two large European studies. Cancer Research. 73: 3625-3625. DOI: 10.1158/1538-7445.Am2013-3625 |
0.677 |
|
| 2012 |
Gonzalez P, Cortes B, Quint W, Kreimer AR, Porras C, Rodríguez AC, Jimenez S, Herrero R, Struijk L, Hildesheim A, Melchers W. Evaluation of the FTA carrier device for human papillomavirus testing in developing countries. Journal of Clinical Microbiology. 50: 3870-6. PMID 22993174 DOI: 10.1128/Jcm.01698-12 |
0.651 |
|
| 2012 |
Castro FA, Quint W, Gonzalez P, Katki HA, Herrero R, van Doorn LJ, Schiffman M, Struijk L, Rodriguez AC, DelVecchio C, Lowy DR, Porras C, Jimenez S, Schiller J, Solomon D, ... ... Kreimer AR, et al. Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. The Journal of Infectious Diseases. 206: 1103-10. PMID 22850119 DOI: 10.1093/Infdis/Jis458 |
0.711 |
|
| 2012 |
Kreimer AR, Schiffman M, Herrero R, Hildesheim A, González P, Burk RD, Porras C, Sherman ME, Demuth F, Cheung L, Bratti C, Cecilia Rodríguez A. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. International Journal of Cancer. Journal International Du Cancer. 131: 211-8. PMID 21823117 DOI: 10.1002/Ijc.26349 |
0.693 |
|
| 2012 |
Shiels MS, Pfeiffer RM, Kreimer AR, Chaturvedi AK, Engels EA. The impact of the HIV epidemic on U.S. anal cancer rates, 1980-2007 Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-O10 |
0.313 |
|
| 2011 |
Herrero R, Wacholder S, RodrÃguez AC, Solomon D, González P, Kreimer AR, Porras C, Schussler J, Jiménez S, Sherman ME, Quint W, Schiller JT, Lowy DR, Schiffman M, Hildesheim A, et al. Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discovery. 1: 408-19. PMID 22586631 DOI: 10.1158/2159-8290.Cd-11-0131 |
0.704 |
|
| 2011 |
Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S, et al. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. Journal of the National Cancer Institute. 103: 1444-51. PMID 21908768 DOI: 10.1093/Jnci/Djr319 |
0.678 |
|
| 2011 |
Kreimer AR, Chaturvedi AK. HPV-associated Oropharyngeal Cancers--Are They Preventable? Cancer Prevention Research (Philadelphia, Pa.). 4: 1346-9. PMID 21893495 DOI: 10.1158/1940-6207.Capr-11-0379 |
0.697 |
|
| 2011 |
Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, et al. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. The Lancet. Oncology. 12: 862-70. PMID 21865087 DOI: 10.1016/S1470-2045(11)70213-3 |
0.716 |
|
| 2011 |
Villa A, Kreimer AR, Pasi M, Polimeni A, Cicciù D, Strohmenger L, Gherlone E, Abati S. Oral cancer knowledge: a survey administered to patients in dental departments at large Italian hospitals. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 26: 505-9. PMID 21207219 DOI: 10.1007/S13187-010-0189-4 |
0.338 |
|
| 2011 |
Kreimer AR, Villa A, Nyitray AG, Abrahamsen M, Papenfuss M, Smith D, Hildesheim A, Villa LL, Lazcano-Ponce E, Giuliano AR. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 172-82. PMID 21148755 DOI: 10.1158/1055-9965.Epi-10-0682 |
0.704 |
|
| 2010 |
Koshiol J, Kreimer AR. Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1889-92. PMID 20696658 DOI: 10.1158/1055-9965.Epi-10-0506 |
0.38 |
|
| 2010 |
Koshiol J, Wei WQ, Kreimer AR, Ren JS, Gravitt P, Chen W, Kim E, Abnet CC, Zhang Y, Kamangar F, Lin DM, Wang GQ, Roth MJ, Dong ZW, Taylor PR, et al. The gastric cardia is not a target for human papillomavirus-induced carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1137-9. PMID 20332262 DOI: 10.1158/1055-9965.Epi-10-0089 |
0.69 |
|
| 2010 |
Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sexually Transmitted Diseases. 37: 386-91. PMID 20081557 DOI: 10.1097/Olq.0B013E3181C94A3B |
0.712 |
|
| 2010 |
Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, Ren JS, Abnet CC, Wang JB, Kamangar F, Lin DM, von Knebel-Doeberitz M, Zhang Y, Viscidi R, Wang GQ, Gillison ML, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of Cancer. Journal International Du Cancer. 127: 93-100. PMID 19918949 DOI: 10.1002/Ijc.25023 |
0.674 |
|
| 2009 |
Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, et al. Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Annals of Family Medicine. 7: 212-22. PMID 19433838 DOI: 10.1370/Afm.942 |
0.31 |
|
| 2009 |
Castle PE, Kreimer AR, Wacholder S, Wheeler CM, Koutsky LA, Rydzak G, Buckman DW, Graubard B, Schiffman M. Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infections. The Journal of Infectious Diseases. 199: 1612-20. PMID 19405865 DOI: 10.1086/598981 |
0.578 |
|
| 2009 |
Kreimer AR. Oral sexual behaviors and the prevalence of oral human papillomavirus infection. The Journal of Infectious Diseases. 199: 1253-4. PMID 19320591 DOI: 10.1086/597756 |
0.674 |
|
| 2008 |
Kovacic MB, Katki HA, Kreimer AR, Sherman ME. Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. Human Pathology. 39: 1088-95. PMID 18495212 DOI: 10.1016/J.Humpath.2007.12.002 |
0.559 |
|
| 2007 |
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. The New England Journal of Medicine. 356: 1944-56. PMID 17494927 DOI: 10.1056/Nejmoa065497 |
0.659 |
|
| 2007 |
Xi LF, Kiviat NB, Wheeler CM, Kreimer A, Ho J, Koutsky LA. Risk of cervical intraepithelial neoplasia grade 2 or 3 after loop electrosurgical excision procedure associated with human papillomavirus type 16 variants. The Journal of Infectious Diseases. 195: 1340-4. PMID 17397005 DOI: 10.1086/513441 |
0.622 |
|
| 2007 |
Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE. Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 11-6. PMID 17220326 DOI: 10.1158/1055-9965.Epi-06-0710 |
0.689 |
|
| 2007 |
Miller JH, Kramer BS, Kreimer AR, Prorok PC, Xu J, Baker SG, Fagerstrom R, Berg CD, Gohagan JK. Cumulative false-positives (FP) in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial Journal of Clinical Oncology. 25: 1503-1503. DOI: 10.1200/Jco.2007.25.18_Suppl.1503 |
0.311 |
|
| 2006 |
Kreimer AR, Guido RS, Solomon D, Schiffman M, Wacholder S, Jeronimo J, Wheeler CM, Castle PE. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 908-14. PMID 16702369 DOI: 10.1158/1055-9965.Epi-05-0845 |
0.69 |
|
| 2006 |
Kreimer AR, Randi G, Herrero R, Castellsagué X, La Vecchia C, Franceschi S. Diet and body mass, and oral and oropharyngeal squamous cell carcinomas: analysis from the IARC multinational case-control study. International Journal of Cancer. Journal International Du Cancer. 118: 2293-7. PMID 16331628 DOI: 10.1002/Ijc.21577 |
0.303 |
|
| 2005 |
Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 467-75. PMID 15734974 DOI: 10.1158/1055-9965.Epi-04-0551 |
0.692 |
|
| 2005 |
Kreimer AR, Clifford GM, Snijders PJ, Castellsagué X, Meijer CJ, Pawlita M, Viscidi R, Herrero R, Franceschi S. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. International Journal of Cancer. Journal International Du Cancer. 115: 329-32. PMID 15688391 DOI: 10.1002/Ijc.20872 |
0.671 |
|
| 2004 |
Kreimer AR, Alberg AJ, Viscidi R, Gillison ML. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sexually Transmitted Diseases. 31: 247-56. PMID 15028941 DOI: 10.1097/01.Olq.0000118425.49522.2C |
0.759 |
|
| 2004 |
Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. The Journal of Infectious Diseases. 189: 686-98. PMID 14767823 DOI: 10.1086/381504 |
0.746 |
|
| Show low-probability matches. |